In this report, we present the results of a study that aimed to estimate the prevalence of problematic opioid use in Ireland from 2015 to 2019 using a four-source capture-recapture method. Three of the four data sources used for the analysis were derived from opioid substitution treatment records from the Central Treatment List (CTL) (clinics, […]
The 2021 report provides data presented nationally as well as: CHO county hospital type individual psychiatric units/hospitals
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
Contents include: Chairperson and Chief Executive’s report; a snapshot of important HRB activities during 2021; key deliverables in line with the HRB Strategy 2021-2025, Health research – making an impact; and Appendices. Part 2 contains the corporate governance and financial statements which have been approved by the Office of the Comptroller and Auditor General. This will […]
Irish results for the European web survey 2021
This is the annual, updated bulletin from the National Drug Treatment Reporting System (NDTRS) on cases of treated problem alcohol use in Ireland. This bulletin covers the period 2015 to 2021, in which 50,304 cases were treated for alcohol as a main problem drug during this seven-year period.
This is the annually updated bulletin from the National Drug Treatment Reporting System (NDTRS) on cases of treated problem drug use (excluding alcohol) in Ireland. It covers the period 2015 to 2021. In this seven-year period, 69,450 cases were treated for drug use as a main problem.
In most developed countries, substance use is a major public health issue, particularly among young people. Alcohol and other drug use is one of the leading risk factors for disease and injury and is also responsible for a considerable number of premature deaths. The National Drug Strategy in Ireland aims to prevent early substance use […]
Under the auspices of Healthy Ireland, the Department of Health is leading the development of the National Healthy Workplace Framework in partnership with the Department of Enterprise, Trade and Employment. The framework aims to drive engagement and identify effective approaches to health improvement in all workplaces. A review of the evidence (carried out by the […]
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
Globally, problem gambling prevalence is estimated at between 0.1% and 5.8%. Problem gambling can have many negative consequences; including on physical, and psychological health, and social functioning. There is a need to better understand treatment uptake as only a small proportion seek treatment. This is the first Irish national study using routinely gathered health surveillance […]
The purpose of this overview of reviews is to provide evidence to assist with the development of clinical guidelines on the management of non-cavitated and cavitated caries in primary and permanent teeth. Cavitated caries include caries in both crown and root of the tooth. Caries (dental decay) is a disease of the hard tissues of […]
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
This report presents the findings from the 2019–20 National Drug and Alcohol Survey (NDAS) on the prevalence of gambling and problem gambling in the general population in Ireland. While the main objective of the 2019–20 NDAS was to determine the prevalence and patterns of drug use (including alcohol and tobacco use), a set of questions on gambling in Ireland […]
This publication contains the 2020 corporate governance and financial statements of the Health Research Board, which have been approved by the Office of the Comptroller and Auditor General. Part one is also available for download (below), and contains a Chairperson and Chief Executive’s report; a timeline of the HRB’s key initiatives in response to the COVID-19 pandemic during […]
This report presents a snapshot of the outputs, outcomes, and some emerging impacts arising from 170 Health Research Board (HRB) awards (with a combined value of €49.5 million) that completed in 2018 and 2019. Further outputs, outcomes, and impacts can be expected to occur in the years following the completion of these awards. The outputs […]
This year’s Health Research in Action highlights some of the many notable impacts and outcomes of the Health Research Board’s work during 2020 across health and social care in Ireland, all of which made a real difference to people’s health, the health system, society, and economy.
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
This systematic review of randomized controlled trials (RCTs) evaluated the efficacy and safety of electronic cigarettes (e-cigarettes, ENDS) in helping people who smoke to achieve abstinence compared with electronic non-nicotine delivery systems (ENNDS, no nicotine) or any smoking cessation comparator treatment or combination of treatments at 24-26 weeks and at 52 weeks.
Contents include: Chairperson and Chief Executive’s report; a timeline of the HRB’s key initiatives in response to the COVID-19 pandemic in 2020: a snapshot of other important HRB activities during 2020; key deliverables in line with the HRB strategy 2016-2020; and Appendices. Part 2 contains the corporate governance and financial statements which have been approved by […]
Drugnet Ireland is the Health Research Board’s quarterly drug and alcohol research and policy newsletter. It provides summaries and analysis of recent publications and policy developments and well as overviews of particular issues relating to the drug and alcohol situation Ireland. Experts from the EMCDDA national focal point and from the HRB Evidence Centre contribute […]
Many different reimbursement systems exist for providers offering healthcare to service users in their homes or residential settings. Under case mix classification systems, service users are sorted into “care bands”, which group together service users with similar levels of care needs. Funding and resources are then allocated to providers based on the care bands of […]
Reablement services help older people accommodate illness or disability by helping them to learn or re-learn skills necessary for daily living. They are typically provided for a period of 6-12 weeks, and during this period they seek to enable older people to be as independent as possible in their day-to-day lives. The provision of reablement […]
This is the annually updated bulletin from the National Drug Treatment Reporting System (NDTRS) on cases of treated problem drug use (excluding alcohol) in Ireland. It covers the period 2014 to 2020. In this seven-year period, 68,571 cases were treated for drug use as a main problem.
This is the annually updated bulletin from the National Drug Treatment Reporting System (NDTRS) on cases of treated problem alcohol use in Ireland. It covers the period 2014 to 2020. In this seven-year period, 51,205 cases were treated for alcohol as a main problem drug.
